Myopathies

Myopathies are genetic or acquired disorders of skeletal muscle that lead to varying degrees of weakness, atrophy, and exercise intolerance. Here are the latest discoveries pertaining to this disease.

January 17, 2021

Effect of long term enzyme replacement therapy in late onset Pompe disease: A single-centre experience

Neuromuscular Disorders : NMD
George K PapadimasConstantinos Papadopoulos
January 19, 2021

Giovanni Nigro and the Naples's school: historical contribution to the knowledge of heart involvement in Duchenne/Becker muscular dystrophies

Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
Luisa Politano
January 19, 2021
Case Report

Refractory dermatomyositis-systemic lupus erythematosus overlap syndrome and response to tofacitinib

Proceedings
Preston Williams, Benjamin McKinney
January 17, 2021
Open Access

The product of trunk muscle area and density on the CT image is a good indicator of energy expenditure in patients with or at risk for COPD

Respiratory Research
Toru ShirahataHidetoshi Nakamura
January 17, 2021

Analysis of complex structural variants in the DMD gene in one family

Neuromuscular Disorders : NMD
Leonela LuceFlorencia Giliberto
January 19, 2021

Dominant or recessive mutations in the RYR1 gene causing central core myopathy in Brazilian patients

Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
Leonardo Galleni LeãoMariz Vainzof
January 16, 2021
Review

Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians

Revue neurologique
A MauryE Meppiel
January 17, 2021

Morphological study of TNPO3 and SRSF1 interaction during myogenesis by combining confocal, structured illumination and electron microscopy analysis

Molecular and Cellular Biochemistry
Roberta CostaGiovanna Cenacchi
January 19, 2021

Core myopathies - a short review

Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
Haluk Topaloglu
January 17, 2021

Remission in Cushing's disease is predicted by cortisol burden and its withdrawal following pituitary surgery

Journal of Endocrinological Investigation
A DuttaU N Saikia
January 19, 2021

HMG-CoA reductase inhibitors (Statins) and their Drug Interactions involving CYP enzymes, P-glycoprotein and OATP Transporters - An Overview

Current Drug Metabolism
Rajkapoor Balasubramanian, Naina Mohamed Pakkir Maideen
January 19, 2021

Myotonic dystrophy type 2: the 2020 update

Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
Giovanni Meola
January 16, 2021
Review
Open Access

A Pound of Flesh: What Cachexia Is and What It Is Not

Diagnostics
Emanuele BerardiDario Coletti
January 19, 2021

Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy

Internal Medicine
Tetsuro YokokawaYasuchika Takeishi

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/myopathies/9de930b7-b10d-4f2c-9057-57af8e13ec88